American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Guidelines. Guidelines for Referral and Management of systemic lupus erythematosus in adults. Arthritis Rheum. 1999, 42: 1785-1796. 10.1002/1529-0131(199909)42:9<1785::AID-ANR1>3.0.CO;2-#.
Petri M: Long-term outcomes in lupus. Am J Managed Care. 2001, 7: S480-S485.
CAS
Google Scholar
Bengtsson AA, Sturfelt G, Truedsson L, Blomberg J, Alm G, Vallin H, Rönnblom L: Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Lupus. 2000, 9: 664-671. 10.1191/096120300674499064.
Article
CAS
PubMed
Google Scholar
Rönnblom L, Alm GV: Systemic lupus erythematosus and the type I interferon system. Arthritis Res Ther. 2003, 5: 68-75. 10.1186/ar625.
Article
PubMed Central
PubMed
Google Scholar
Banchereau J, Pascual V, Palucka AK: Autoimmunity through cytokine-induced dendritic cell activation. Immunity. 2004, 20: 539-550. 10.1016/S1074-7613(04)00108-6.
Article
CAS
PubMed
Google Scholar
Baechler EC, Gregersen PK, Behrens TW: The emerging role of interferon in human systemic lupus erythematosus. Curr Opin Immunol. 2004, 16: 801-807. 10.1016/j.coi.2004.09.014.
Article
CAS
PubMed
Google Scholar
Dall'era MC, Cardarelli PM, Preston BT, Witte A, Davis JC: Type I interferon correlates with clinical and serologic manifestations of systemic lupus erythematosus. Ann Rheum Dis. 2005, 64: 1692-1697. 10.1136/ard.2004.033753.
Article
PubMed Central
PubMed
Google Scholar
Crow M: Interferon-α: a new target for therapy in systemic lupus erythematosus?. Arthritis Rheum. 2003, 48: 2396-2401. 10.1002/art.11226.
Article
CAS
PubMed
Google Scholar
Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, Harley JB: Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med. 2003, 349: 1526-1533. 10.1056/NEJMoa021933.
Article
CAS
PubMed
Google Scholar
Pascual V, Farkas L, Banchereau J: Systemic lupus erythematosus: all roads lead to type I interferons. Curr Opin Immunol. 2006, 18: 676-682. 10.1016/j.coi.2006.09.014.
Article
CAS
PubMed
Google Scholar
Rönnblom L, Pascual V: The innate immune system in SLE: type I interferons and dendritic cells. Lupus. 2008, 17: 394-399. 10.1177/0961203308090020.
Article
PubMed Central
PubMed
Google Scholar
Theofilopoulos AN, Baccala R, Beutler B, Kono DH: Type I Interferons (a/b) in immunity and autoimmunity. Annu Rev Immunol. 2005, 23: 307-336. 10.1146/annurev.immunol.23.021704.115843.
Article
CAS
PubMed
Google Scholar
Mailliard RB, Son YI, Redlinger R, Coates PT, Giermasz A, Morel PA, Storkus WJ, Kalinski P: Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function. J Immunol. 2003, 171: 2366-2373.
Article
CAS
PubMed
Google Scholar
Biron CA: Interferons α and β as immune regulators - a new look. Immunity. 2001, 14: 661-664. 10.1016/S1074-7613(01)00154-6.
Article
CAS
PubMed
Google Scholar
Bussfeld D, Nain M, Hoffman P, Gemsa D, Sprenger H: Selective induction of the monocyte-attracting chemokines MCP-1 and IP-10 in vesicular stomatitis virus-infected human monocytes. J Interferon Cytokine Res. 2000, 20: 615-621. 10.1089/107999000414781.
Article
CAS
PubMed
Google Scholar
Pogue SL, Preston BT, Stalder J, Bebbington CR, Cardarelli PM: The receptor for type I IFNs is highly expressed on peripheral blood B cells and monocytes and mediates a distinct profile of differentiation and activation of these cells. J Interferon Cytokine Res. 2004, 24: 131-139. 10.1089/107999004322813372.
Article
CAS
PubMed
Google Scholar
Salazar-Mather TP, Hokeness KL: Calling in the troops: regulation of inflammatory cell trafficking through innate cytokine/chemokine networks. Viral Immunol. 2003, 16: 291-306. 10.1089/088282403322396109.
Article
CAS
PubMed
Google Scholar
Criswell LA: The genetic contribution to systemic lupus erythematosus. Bull NYU Hosp Jt Dis. 2008, 66: 176-183.
PubMed
Google Scholar
Sigurdsson S, Göring HH, Kristjansdottir G, Milani L, Nordmark G, Sandling JK, Eloranta ML, Feng D, Sangster-Guity N, Gunnarsson I, Svenungsson E, Sturfelt G, Jönsen A, Truedsson L, Barnes BJ, Alm G, Rönnblom L, Syvänen AC: Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus. Hum Mol Genet. 2008, 17: 872-881. 10.1093/hmg/ddm359.
Article
CAS
PubMed
Google Scholar
Niewold TB, Swedler WI: Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C. Clin Rheumatol. 2005, 24: 178-181. 10.1007/s10067-004-1024-2.
Article
PubMed
Google Scholar
Ioannou Y, Isenberg DA: Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy. Arthritis Rheum. 2000, 43: 1431-1442. 10.1002/1529-0131(200007)43:7<1431::AID-ANR3>3.0.CO;2-E.
Article
CAS
PubMed
Google Scholar
Mathian A, Weinberg A, Gallegos M, Banchereau J, Koutouzov F: IFNα induces early lethal lupus in preautoimmune (New Zealand Black × New Zealand White) F1 but not in BALB/c mice. J Immunol. 2005, 174: 2499-2506.
Article
CAS
PubMed
Google Scholar
Santiago-Raber ML, Baccala R, Haraldsson KM, Choubey D, Stewart TA, Kono DH, Theofilopoulis AN: Type I interferon receptor deficiency reduces lupuslike disease in NZB mice. J Exp Med. 2003, 197: 777-788. 10.1084/jem.20021996.
Article
PubMed Central
CAS
PubMed
Google Scholar
Zagury D, Le Buanec H, Mathian A, Larcier P, Burnett R, Amoura Z, Emilie D, Peltre G, Bensussan A, Bizzini B, Gallo RC, Koutouzov S: IFNα kinoid vaccine-induced neutralizing antibodies prevent clinical manifestations in a lupus flare murine model. Proc Natl Acad Sci USA. 2009, 106: 5294-5299. 10.1073/pnas.0900615106.
Article
PubMed Central
CAS
PubMed
Google Scholar
Sotiriou C, Pusztai L: Gene-expression signatures in breast cancer. N Engl J Med. 2009, 360: 790-800. 10.1056/NEJMra0801289.
Article
CAS
PubMed
Google Scholar
Siena S, Sartore-Bianchi A, Di Nicolantonio F, Balfour J, Bardelli A: Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer. J Natl Cancer Inst. 2009, 101: 1308-1324. 10.1093/jnci/djp280.
Article
PubMed Central
CAS
PubMed
Google Scholar
Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR: MicroRNA expression profiles classify human cancers. Nature. 2005, 435: 834-838. 10.1038/nature03702.
Article
CAS
PubMed
Google Scholar
Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T, Hiller W, Fisher ER, Wickerham DL, Bryant J, Wolmark N: A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004, 351: 2817-2826. 10.1056/NEJMoa041588.
Article
CAS
PubMed
Google Scholar
Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Ortmann WA, Espe KJ, Shark KB, Grande WJ, Hughes KM, Kapur V, Gregersen PK, Behrens TW: Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci USA. 2003, 100: 2610-2615. 10.1073/pnas.0337679100.
Article
PubMed Central
CAS
PubMed
Google Scholar
Bennett L, Palucka AK, Arce E, Cantrell V, Borvak J, Banchereau J, Pascual V: Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med. 2003, 197: 711-723. 10.1084/jem.20021553.
Article
PubMed Central
CAS
PubMed
Google Scholar
Han GM, Chen SL, Shen N, Ye S, Bao CD, Gu YY: Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray. Genes Immun. 2003, 4: 177-186. 10.1038/sj.gene.6363966.
Article
CAS
PubMed
Google Scholar
Kirou KA, Lee C, George S, Louca K, Papagiannis IG, Peterson MG, Ly N, Woodward RN, Fry KE, Lau AY, Prentice JG, Wohlgemuth JG, Crow MK: Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus. Arthritis Rheum. 2004, 50: 3958-3967. 10.1002/art.20798.
Article
CAS
PubMed
Google Scholar
Kirou KA, Lee C, George S, Louca K, Peterson MG, Crow MK: Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis Rheum. 2005, 52: 1491-1503. 10.1002/art.21031.
Article
CAS
PubMed
Google Scholar
Feng X, Wu H, Grossman JM, Hanvivadhanakul P, FitzGerald JD, Park GS, Dong X, Chen W, Kim MH, Weng HH, Furst DE, Gorn A, McMahon M, Taylor M, Brahn E, Hahn BH, Tsao BP: Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus. Arthritis Rheum. 2006, 54: 2951-2962. 10.1002/art.22044.
Article
CAS
PubMed
Google Scholar
Yao Y, Higgs BW, Morehouse C, de los Reyes M, Brohawn P, Trigona W, White W, Zhang J, White B, Coyle AJ, Kiener PA, Jallal B: Development of potential pharmacodynamic and diagnostic markers for anti-IFN-α monoclonal antibody trials in systemic lupus erythematosus. Human Genomics Proteomics. 2008, 2009: article 374312-doi:10.4061/2009/374312.
Google Scholar
Blomberg S, Eloranta ML, Cederblad B, Nordlin K, Alm GV, Rönnblom L: Presence of cutaneous interferon-alpha producing cells in patients with systemic lupus erythematosus. Lupus. 2001, 10: 484-490. 10.1191/096120301678416042.
Article
CAS
PubMed
Google Scholar
Farkas L, Beiske K, Lund-Johansen F, Brandtzaeg P, Jahnsen FL: Plasmacytoid dendritic cells (natural interferon-alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am J Pathol. 2001, 159: 237-243.
Article
PubMed Central
CAS
PubMed
Google Scholar
Yao Y, Richman L, Higgs BW, Morehouse CA, de los Reyes M, Brohawn P, Zhang J, White B, Coyle AJ, Kiener PA, Jallal B: Neutralization of IFN-α/β-inducible genes and downstream effect in a phase i trial of an anti-IFN-α monoclonal antibody in SLE. Arthritis Rheum. 2009, 60: 1785-1796. 10.1002/art.24557.
Article
CAS
PubMed
Google Scholar
Okamoto H, Katsumata Y, Nishimura K, Kamatani N: Interferon-inducible protein 10/CXCL10 is increased in cerebrospinal fluid of patients with central nervous system lupus. Arthritis Rheum. 2004, 50: 3731-3732. 10.1002/art.20598.
Article
CAS
PubMed
Google Scholar
Nzeusseu Toukap A, Galant C, Theate I, Maudoux AL, Lories RJ, Houssiau FA, Lauwerys BR: Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus. Arthritis Rheum. 2007, 56: 1579-1588. 10.1002/art.22578.
Article
CAS
PubMed
Google Scholar
Hua J, Kirou K, Lee C, Crow MK: Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies. Arthritis Rheum. 2006, 54: 1906-1916. 10.1002/art.21890.
Article
CAS
PubMed
Google Scholar
Walsh RJ, Kong SW, Yao Y, Jallal B, Kiener PA, Pinkus JL, Beggs AH, Amato AA, Greenberg SA: Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis. Arthritis Rheum. 2007, 56: 3784-3792. 10.1002/art.22928.
Article
PubMed Central
CAS
PubMed
Google Scholar
Kraan van der Pouw TC, Wijbrandts CA, van Baarsen LG, Voskuyl AE, Rustenburg F, Baggen JM, Ibrahim SM, Fero M, Dijkmans BA, Tak PP, Verweij CL: Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients. Ann Rheum Dis. 2007, 66: 1008-1014. 10.1136/ard.2006.063412.
Article
Google Scholar
Båve U, Nordmark G, Lövgren T, Rönnelid J, Cajander S, Eloranta ML, Alm GV, Rönnblom L: Activation of the type I interferon system in primary Sjogren's syndrome: a possible etiopathogenic mechanism. Arthritis Rheum. 2005, 52: 1185-1195. 10.1002/art.20998.
Article
PubMed
Google Scholar
Zheng L, Zhang Z, Yu C, Tu L, Zhong L, Yang C: Association between IFN-alpha and primary Sjogren's syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009, 107: e12-e18. 10.1016/j.tripleo.2008.09.015.
Article
PubMed
Google Scholar
Duan H, Fleming J, Pritchard DK, Amon LM, Xue J, Arnett HA, Chen G, Breen P, Buckner JH, Molitor JA, Elkon KB, Schwartz SM: Combined analysis of monocyte and lymphocyte messenger RNA expression with serum protein profiles in patients with scleroderma. Arthritis Rheum. 2008, 58: 1465-1474. 10.1002/art.23451.
Article
CAS
PubMed
Google Scholar
Greenberg SA, Pinkus JL, Pinkus GS, Burleson T, Sanoudou D, Tawil R, Barohn RJ, Saperstein DS, Briemberg HR, Ericsson M, Park P, Amato AA: Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis. Ann Neurol. 2005, 57: 664-678. 10.1002/ana.20464.
Article
CAS
PubMed
Google Scholar
Whitfield ML, Finlay DR, Murray JI, Troyanskaya OG, Chi JT, Pergamenschikov A, McCalmont TH, Brown PO, Botstein D, Connolly MK: Systemic and cell type-specific gene expression patterns in scleroderma skin. Proc Natl Acad Sci USA. 2003, 100: 12319-12324. 10.1073/pnas.1635114100.
Article
PubMed Central
CAS
PubMed
Google Scholar
Wallace DJ, Petri M, Olsen N, Kirou K, Dennis G, Yao Y, Jallal B, Coyle A, Zeng L: MEDI-545, an anti-interferon alpha monoclonal antibody, shows evidence of clinical activity in systemic lupus erythematous [abstract 1325]. Arthritis Rheum. 2007, 56: S526-S527.
Google Scholar
McBride JM, Wallace DJ, Yao Z, Morimoto A, Jiang J, Maciuca R, McLean I, Drappa J: Dose-dependent modulation of interferon regulated genes with administration of single and repeat doses of Rontalizumab in a phase I, placebo controlled, double blind, dose escalation study in SLE [abstract 2072]. Arthritis Rheum. 2009, 60: S775-S776.
Google Scholar